Package 76282-738-30

Brand: darunavir

Generic: darunavir 800 mg
NDC Package

Package Facts

Identity

Package NDC 76282-738-30
Digits Only 7628273830
Product NDC 76282-738
Product ID 76282-738_d4f6fed4-1a95-4d9a-8395-13818dedccd3
Description

30 TABLET in 1 BOTTLE (76282-738-30)

Marketing

Marketing Status
Marketed Since 2024-01-19
Brand darunavir
Generic darunavir 800 mg
Sample Package No

Linked Drug Pages (1)

darunavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d4f6fed4-1a95-4d9a-8395-13818dedccd3", "openfda": {"upc": ["0376282737607", "0376282738307"], "unii": ["KPC4NRB25L"], "rxcui": ["670026", "1359269"], "spl_set_id": ["ed977166-7ac0-4a8c-a10c-4b19a69403c0"], "manufacturer_name": ["EXELAN PHARMACEUTICALS INC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (76282-738-30)", "package_ndc": "76282-738-30", "marketing_start_date": "20240119"}], "brand_name": "darunavir", "product_id": "76282-738_d4f6fed4-1a95-4d9a-8395-13818dedccd3", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "76282-738", "generic_name": "darunavir 800 mg", "labeler_name": "EXELAN PHARMACEUTICALS INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "darunavir", "active_ingredients": [{"name": "DARUNAVIR HYDRATE", "strength": "800 mg/1"}], "application_number": "ANDA206288", "marketing_category": "ANDA", "marketing_start_date": "20240119", "listing_expiration_date": "20261231"}